44 related articles for article (PubMed ID: 38601438)
1. Mitotic syndicates Aurora Kinase B (AURKB) and mitotic arrest deficient 2 like 2 (MAD2L2) in cohorts of DNA damage response (DDR) and tumorigenesis.
Marima R; Hull R; Penny C; Dlamini Z
Mutat Res Rev Mutat Res; 2021; 787():108376. PubMed ID: 34083040
[TBL] [Abstract][Full Text] [Related]
2. Aurora kinase B inhibition in small-cell lung cancer: BCL-2 as a potential therapeutic biomarker and combination target.
Hosoya K; Ozasa H
Transl Lung Cancer Res; 2024 Mar; 13(3):689-693. PubMed ID: 38601438
[No Abstract] [Full Text] [Related]
3. Aurora kinase targeting in lung cancer reduces KRAS-induced transformation.
Dos Santos EO; Carneiro-Lobo TC; Aoki MN; Levantini E; Bassères DS
Mol Cancer; 2016 Feb; 15():12. PubMed ID: 26842935
[TBL] [Abstract][Full Text] [Related]
4. Relation of
Huang D; Huang Y; Huang Z; Weng J; Zhang S; Gu W
Cancer Cell Int; 2019; 19():166. PubMed ID: 31244554
[TBL] [Abstract][Full Text] [Related]
5. Daurinol Enhances the Efficacy of Radiotherapy in Lung Cancer via Suppression of Aurora Kinase A/B Expression.
Woo JK; Kang JH; Shin D; Park SH; Kang K; Nho CW; Seong JK; Lee SJ; Oh SH
Mol Cancer Ther; 2015 Jul; 14(7):1693-704. PubMed ID: 25882311
[TBL] [Abstract][Full Text] [Related]
6. Cells Lacking the
Oser MG; Fonseca R; Chakraborty AA; Brough R; Spektor A; Jennings RB; Flaifel A; Novak JS; Gulati A; Buss E; Younger ST; McBrayer SK; Cowley GS; Bonal DM; Nguyen QD; Brulle-Soumare L; Taylor P; Cairo S; Ryan CJ; Pease EJ; Maratea K; Travers J; Root DE; Signoretti S; Pellman D; Ashton S; Lord CJ; Barry ST; Kaelin WG
Cancer Discov; 2019 Feb; 9(2):230-247. PubMed ID: 30373918
[TBL] [Abstract][Full Text] [Related]
7. Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer.
Ramkumar K; Tanimoto A; Della Corte CM; Stewart CA; Wang Q; Shen L; Cardnell RJ; Wang J; Polanska UM; Andersen C; Saeh J; Pease JE; Travers J; Fabbri G; Gay CM; Urosevic J; Byers LA
Clin Cancer Res; 2023 Aug; 29(16):3237-3249. PubMed ID: 37289191
[TBL] [Abstract][Full Text] [Related]
8. Targeted Therapies in Small Cell Lung Cancer: From Old Failures to Novel Therapeutic Strategies.
Cani M; Napoli VM; Garbo E; Ferrari G; Del Rio B; Novello S; Passiglia F
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240229
[TBL] [Abstract][Full Text] [Related]
9. Aurora B Inhibitors as Cancer Therapeutics.
Kovacs AH; Zhao D; Hou J
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110619
[TBL] [Abstract][Full Text] [Related]
10. Targeting Acute Myeloid Leukemia with Venetoclax; Biomarkers for Sensitivity and Rationale for Venetoclax-Based Combination Therapies.
Griffioen MS; de Leeuw DC; Janssen JJWM; Smit L
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884517
[TBL] [Abstract][Full Text] [Related]
11. Cancer statistics, 2022.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2022 Jan; 72(1):7-33. PubMed ID: 35020204
[TBL] [Abstract][Full Text] [Related]
12. Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis.
Tanaka K; Yu HA; Yang S; Han S; Selcuklu SD; Kim K; Ramani S; Ganesan YT; Moyer A; Sinha S; Xie Y; Ishizawa K; Osmanbeyoglu HU; Lyu Y; Roper N; Guha U; Rudin CM; Kris MG; Hsieh JJ; Cheng EH
Cancer Cell; 2021 Sep; 39(9):1245-1261.e6. PubMed ID: 34388376
[TBL] [Abstract][Full Text] [Related]
13. Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer.
Borah NA; Reddy MM
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915740
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]